Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Therapeutic effects of oxygen supplementation in mouse fetuses with congenital heart disease

FY 2021-22

Summary
Therapeutic effects of oxygen supplementation in mouse fetuses with congenital heart diseaseCongenital heart disease (CHD), where the fetal heart fails to form or grow normally, is one of the leading causes of death in infancy. Brain development in these children is often altered and is thought to be caused, at least in part, by reduced supply of oxygen to the brain prior to birth. The importance of oxygen in early life is highlighted by a recent scientific study demonstrating that increasing oxygen concentration in a fetal mouse brain during mid-pregnancy changes the way the brain grows. I propose to assess the effect of oxygen supplementation on fetal brain development in mice with Hypoplastic Left Heart Syndrome (HLHS), a form of CHD characterized by an underdevelopment of the left side of the heart. My hypothesis is that maternal oxygen supplementation during the middle period of embryonic development will increase oxygen supply and rescue normal brain development in fetuses with HLHS. HLHS will be induced in fetuses by surgically obstructing the left fetal heart at mid-pregnancy to block blood flow and induce underdevelopment in this region. The pregnant dams will then be exposed to an air chamber filled with either ambient or more concentrated oxygen for 48 hours. Magnetic Resonance Imaging (MRI), a tool to visualize body organs and tissues, will be used to measure brain volumes to compare the extent of brain development between fetuses from the two oxygen treatment groups. After MRI, cellular oxygen levels will be quantified to understand whether these brain cells are energetically equipped for further growth and proliferation. This proposed oxygen supplementation study will give insight on how to improve outcomes for children affected by this condition.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
467136
Name
Zhou Linqiao
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Therapeutic effects of oxygen supplementation in mouse fetuses with congenital heart disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood Circulation; Brain Development; Brain Hypoxia; Congenital Heart Disease; Heart Embolization Surgery; Immunohistochemistry; Magnetic Resonance Imaging; Mouse Model; Oxygen Therapy; Pregnancy
Abstract
Therapeutic effects of oxygen supplementation in mouse fetuses with congenital heart diseaseCongenital heart disease (CHD), where the fetal heart fails to form or grow normally, is one of the leading causes of death in infancy. Brain development in these children is often altered and is thought to be caused, at least in part, by reduced supply of oxygen to the brain prior to birth. The importance of oxygen in early life is highlighted by a recent scientific study demonstrating that increasing oxygen concentration in a fetal mouse brain during mid-pregnancy changes the way the brain grows. I propose to assess the effect of oxygen supplementation on fetal brain development in mice with Hypoplastic Left Heart Syndrome (HLHS), a form of CHD characterized by an underdevelopment of the left side of the heart. My hypothesis is that maternal oxygen supplementation during the middle period of embryonic development will increase oxygen supply and rescue normal brain development in fetuses with HLHS. HLHS will be induced in fetuses by surgically obstructing the left fetal heart at mid-pregnancy to block blood flow and induce underdevelopment in this region. The pregnant dams will then be exposed to an air chamber filled with either ambient or more concentrated oxygen for 48 hours. Magnetic Resonance Imaging (MRI), a tool to visualize body organs and tissues, will be used to measure brain volumes to compare the extent of brain development between fetuses from the two oxygen treatment groups. After MRI, cellular oxygen levels will be quantified to understand whether these brain cells are energetically equipped for further growth and proliferation. This proposed oxygen supplementation study will give insight on how to improve outcomes for children affected by this condition.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhou, Linqiao
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~